Literature DB >> 23860300

Overlap of diseases underlying ischemic stroke: the ASCOD phenotyping.

Gaia Sirimarco1, Philippa C Lavallée, Julien Labreuche, Elena Meseguer, Lucie Cabrejo, Céline Guidoux, Isabelle F Klein, Jean-Marc Olivot, Halim Abboud, Valérie Adraï, Jérôme Kusmierek, Samina Ratani, Pierre-Jean Touboul, Mikael Mazighi, Philippe Gabriel Steg, Pierre Amarenco.   

Abstract

BACKGROUND AND
PURPOSE: ASCOD phenotyping (A, atherosclerosis; S, small vessel disease; C, cardiac pathology; O, other causes; and D, dissection) assigns a degree of likelihood to every potential cause (1 for potentially causal, 2 for causality is uncertain, 3 for unlikely causal but disease is present, 0 for absence of disease, and 9 for insufficient workup to rule out the disease) commonly encountered in ischemic stroke. We used ASCOD to investigate the overlap of underlying vascular diseases and their prognostic implication.
METHODS: A single rater applied ASCOD in 405 patients enrolled in the Asymptomatic Myocardial Ischemia in Stroke and Atherosclerotic Disease study.
RESULTS: A was present in 90% of patients (A1=43% and A2=15%), C in 52% (C1=23% and C2=14%), and S in 66% (S1=11% and S2=2%). On the basis of grades 1 and 2, 25% of patients had multiple underlying diseases, and 80% when all 3 grades were considered. The main overlap was found between A and C; among C1 patients, A was present in 92% of cases (A1=28%, A2=20%, and A3=44%). Conversely, among A1 patients, C was present in 47% of cases (C1=15%, C2=15%, and C3=17%). Grades for C were associated with gradual increase in the 3-year risk of vascular events, whereas risks were similar across A grades, meaning that the mere presence of atherosclerotic disease qualifies for high risk, regardless the degree of likelihood for A.
CONCLUSIONS: ASCOD phenotyping shows that the large overlap among the 3 main diseases, and the high prevalence of any form of atherosclerotic disease, reinforces the need to systematically control atherosclerotic risk factors in all ischemic strokes.

Entities:  

Keywords:  atherosclerosis; etiology; stroke

Mesh:

Year:  2013        PMID: 23860300     DOI: 10.1161/STROKEAHA.113.001363

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

Review 1.  Small vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.

Authors:  Christian Schenk; Timothy Wuerz; Alan J Lerner
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

2.  Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease.

Authors:  Takao Hoshino; Leila Sissani; Julien Labreuche; Gregory Ducrocq; Philippa C Lavallée; Elena Meseguer; Céline Guidoux; Lucie Cabrejo; Cristina Hobeanu; Fernando Gongora-Rivera; Pierre-Jean Touboul; Philippe Gabriel Steg; Pierre Amarenco
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

Review 3.  Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee.

Authors:  Ana Verdelho; Joanna Wardlaw; Aleksandra Pavlovic; Leonardo Pantoni; Olivier Godefroy; Marco Duering; Andreas Charidimou; Hugues Chabriat; Geert Jan Biessels
Journal:  Eur Stroke J       Date:  2021-02-28

Review 4.  Promising Biomarker Candidates for Cardioembolic Stroke Etiology. A Brief Narrative Review and Current Opinion.

Authors:  Arnold Markus; Schütz Valerie; Katan Mira
Journal:  Front Neurol       Date:  2021-02-25       Impact factor: 4.003

5.  Cardiovascular diseases in patients 65 years and younger with non-cardiogenic stroke.

Authors:  Anetta Lasek-Bal; Zbigniew Gąsior
Journal:  Arch Med Sci       Date:  2016-05-18       Impact factor: 3.318

6.  Phenotypic ASCOD characterisations of ischaemic stroke in the young at an urban tertiary care centre.

Authors:  Angela Liu; Mohsen Pirastehfar; Daohai Yu; Guillermo Linares
Journal:  Stroke Vasc Neurol       Date:  2018-07-30

7.  SARS-CoV-2 and Stroke in a New York Healthcare System.

Authors:  Shadi Yaghi; Koto Ishida; Jose Torres; Brian Mac Grory; Eytan Raz; Kelley Humbert; Nils Henninger; Tushar Trivedi; Kaitlyn Lillemoe; Shazia Alam; Matthew Sanger; Sun Kim; Erica Scher; Seena Dehkharghani; Michael Wachs; Omar Tanweer; Frank Volpicelli; Brian Bosworth; Aaron Lord; Jennifer Frontera
Journal:  Stroke       Date:  2020-05-20       Impact factor: 7.914

8.  In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease.

Authors:  Paolo Zanotti-Fregonara; Clément Morgat; Romain Schollhammer; Sébastien Lepreux; Nicole Barthe; Delphine Vimont; Anne Rullier; Igor Sibon; Xavier Berard; Andrea Zhang; Yasuyuki Kimura; Masahiro Fujita; Robert B Innis
Journal:  EJNMMI Res       Date:  2021-05-05       Impact factor: 3.138

9.  Systemic Transcriptional Alterations of Innate and Adaptive Immune Signaling Pathways in Atherosclerosis, Ischemia Stroke, and Myocardial Infarction.

Authors:  Taura L Barr; Reynal L VanGilder; Ryan Seiberg; Ashely Petrone; Paul D Chantler; Chiang-Ching Huang
Journal:  J Bioanal Biomed       Date:  2015-04-03

10.  Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin.

Authors:  Pierre Amarenco; Hans Denison; Scott R Evans; Anders Himmelmann; Stefan James; Mikael Knutsson; Per Ladenvall; Carlos A Molina; Yongjun Wang; S Claiborne Johnston
Journal:  Stroke       Date:  2020-11-16       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.